Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021 - Product Thumbnail Image

Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021

  • Report
  • 148 Pages
From
Cardiovascular Disorders Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Cardiovascular Disorders Drug Development Pipeline Review, 2017

  • Report
  • 432 Pages
From
Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018

  • Report
  • 118 Pages
From
Global Kidney Cancer Drug Market, company profiles, share, trends, analysis, opportunities, segmentation and forecast 2017 - 2023 - Product Thumbnail Image

Global Kidney Cancer Drug Market, company profiles, share, trends, analysis, opportunities, segmentation and forecast 2017 - 2023

  • Report
  • 140 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

  • Report
  • 722 Pages
From
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Insight, 2018 - Product Thumbnail Image

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Cancer Cachexia: Drug Development Pipeline Study, H1 2018 - Product Thumbnail Image

Cancer Cachexia: Drug Development Pipeline Study, H1 2018

  • Report
  • 47 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

  • Report
  • 713 Pages
From
Pancreatic Cancer Therapeutics in Major Developed Markets to 2021: Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape - Product Thumbnail Image

Pancreatic Cancer Therapeutics in Major Developed Markets to 2021: Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape

  • Report
  • 138 Pages
From
Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016 - Product Thumbnail Image

Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016

  • Report
  • 187 Pages
From
Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016 - Product Thumbnail Image

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016

  • Report
  • 169 Pages
From
Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

  • Report
  • 515 Pages
From
AVEO Pharmaceuticals’ and Astellas Pharma’s Tivozanib - Can this angiogenesis inhibitor distinguish itself from the field? - Product Thumbnail Image

AVEO Pharmaceuticals’ and Astellas Pharma’s Tivozanib - Can this angiogenesis inhibitor distinguish itself from the field?

  • Report
  • 37 Pages
From
RCC [2017]: Bulletin #2 - Product Thumbnail Image

RCC [2017]: Bulletin #2

  • Newsletter
From
Ovarian Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2018

  • Report
  • 2412 Pages
From
Pancreatic Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H1 2018

  • Report
  • 2509 Pages
From
Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016 - Product Thumbnail Image

Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • Report
  • 173 Pages
From
Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016 - Product Thumbnail Image

Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • Report
  • 168 Pages
From
Loading Indicator
adroll